For this year's annual report, our staff has compiled, studied andsorted reams of information to offer some insight into 1995 inaddition to a solid review of biotech's accomplishments anddisappointments of 1994.
BioWorld Biotechnology State Of The Industry Report containsanalyses from the scientific, financial and regulatory perspectives ofthe industry. We have enhanced the report with several new features:an overview of product failures; an outline of new FDA rules; a list ofall biopharmaceuticals with sales figures; and a chronology of DavidBlech's troubles.
At 141 pages, it is twice the size of last years' report, providing big-picture overviews and detailed information.
(c) 1997 American Health Consultants. All rights reserved.